Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr 7;7(6):FSO705.
doi: 10.2144/fsoa-2021-0035.

The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities

Elisena Franzese  1 , Stefano De Falco  1 , Maria Maddalena Laterza  1 , Liliana Montella  1 , Sergio Facchini  2 , Carmela Liguori  1 , Paola Coppola  1 , Ylenia Diessa  1 , Massimiliano Berretta  3 , Salvatore Pisconti  4 , Francesco Trama  5 , Matteo Ferro  6 , Felice Crocetto  7 , Morena Fasano  2 , Carlo Buonerba  8   9 , Gaetano Facchini  1
Affiliations
Editorial

The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities

Elisena Franzese et al. Future Sci OA. .
No abstract available

Keywords: PSMA PET; nuclear medicine; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

References

    1. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. (2021). - PubMed
    1. Swami U, McFarland TR, Nussenzveig R, Agarwal N. Advanced prostate cancer: treatment advances and future directions. Trends Cancer 6(8), 702–715 (2020). - PubMed
    1. Chang SS. Overview of prostate-specific membrane antigen. Rev. Urol. 6(Suppl. 10), S13–S18 (2004). - PMC - PubMed
    1. Pastorino S, Riondato M, Uccelli L et al. Toward the discovery and development of psma targeted inhibitors for nuclear medicine applications. Curr. Radiopharm. 13(1), 63–79 (2020). - PMC - PubMed
    1. Scher HI, Morris MJ, Stadler WM et al. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the prostate cancer clinical trials working group 3. J. Clin. Oncol. 34(12), 1402–1418 (2016). - PMC - PubMed

Publication types